Market Wire – DiaMedica Initiates Type 1 Diabetes Study; Announces Preliminary Results

0

July 8, 2010 — DiaMedica Inc., (TSX VENTURE: DMA) today announces that it has initiated a Type 1 diabetes program. The recently announced Sanomune acquisition…

More: continued here

Filed under Acne Treatments by on #

Leave a Comment

Fields marked by an asterisk (*) are required.

This blog is protected by Dave\\\\\\\'s Spam Karma 2: 18738 Spams eaten and counting...